In the past week, EHTH stock has gone down by -0.45%, with a monthly decline of -21.51% and a quarterly plunge of -47.29%. The volatility ratio for the week is 3.82%, and the volatility levels for the last 30 days are 3.91% for eHealth Inc The simple moving average for the past 20 days is 0.09% for EHTH’s stock, with a -30.77% simple moving average for the past 200 days.
Is It Worth Investing in eHealth Inc (NASDAQ: EHTH) Right Now?
EHTH has 36-month beta value of 0.96. Analysts have mixed views on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 4 as “hold,” and 0 as “sell.”
The public float for EHTH is 27.52M, and currently, short sellers hold a 0.68% ratio of that float. The average trading volume of EHTH on June 12, 2025 was 280.53K shares.
EHTH) stock’s latest price update
eHealth Inc (NASDAQ: EHTH)’s stock price has increased by 5.80 compared to its previous closing price of 4.14. However, the company has seen a -0.45% decrease in its stock price over the last five trading sessions. businesswire.com reported 2025-05-29 that NEW YORK–(BUSINESS WIRE)–Consortium for State and Regional Interoperability (CSRI), a collection of the nation’s largest and most robust nonprofit health data networks, announced today the addition of its latest member, New York eHealth Collaborative (NYeC). A nonprofit organization working to improve healthcare and patient outcomes by collaboratively leading, connecting, and integrating health information exchange (HIE) across the state of New York, NYeC is joining founding CSRI members Cont.
Analysts’ Opinion of EHTH
Many brokerage firms have already submitted their reports for EHTH stocks, with UBS repeating the rating for EHTH by listing it as a “Neutral.” The predicted price for EHTH in the upcoming period, according to UBS is $5.50 based on the research report published on December 04, 2024 of the previous year 2024.
Craig Hallum, on the other hand, stated in their research note that they expect to see EHTH reach a price target of $7. The rating they have provided for EHTH stocks is “Hold” according to the report published on January 18th, 2024.
Craig Hallum gave a rating of “Buy” to EHTH, setting the target price at $6 in the report published on December 01st of the previous year.
EHTH Trading at -16.15% from the 50-Day Moving Average
After a stumble in the market that brought EHTH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -61.44% of loss for the given period.
#####
#####
Insider Trading
Reports are indicating that there were more than several insider trading activities at EHTH starting from Galimi Gavin G., who purchase 9,500 shares at the price of $4.32 back on May 28 ’25. After this action, Galimi Gavin G. now owns 243,817 shares of eHealth Inc, valued at $41,037 using the latest closing price.
WOLF DALE B, the Director of eHealth Inc, sale 16,403 shares at $5.22 during a trade that took place back on Nov 11 ’24, which means that WOLF DALE B is holding 88,559 shares at $85,665 based on the most recent closing price.
Stock Fundamentals for EHTH
Current profitability levels for the company are sitting at:
- 0.08 for the present operating margin
- 0.93 for the gross margin
The net margin for eHealth Inc stands at 0.05. The total capital return value is set at 0.05. Equity return is now at value 3.19, with 2.60 for asset returns.
Based on eHealth Inc (EHTH), the company’s capital structure generated 0.14 points at debt to capital in total, while cash flow to debt ratio is standing at -0.13. The debt to equity ratio resting at 0.16. The interest coverage ratio of the stock is 4.21.
Currently, EBITDA for the company is 46.81 million with net debt to EBITDA at -0.38. When we switch over and look at the enterprise to sales, we see a ratio of 0.19. The receivables turnover for the company is 0.6for trailing twelve months and the total asset turnover is 0.49. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.58.
Conclusion
To put it simply, eHealth Inc (EHTH) has had a bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
